Minerva Neurosciences, Inc. (NERV) vs OptimizeRx Corp. (OPRX)
A side-by-side comparison of Minerva Neurosciences, Inc. and OptimizeRx Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
NERV
Minerva Neurosciences, Inc.
$3.44HealthcareDelayed quote: Oct 6, 2026, 1:48 PM EDT
OPRX
OptimizeRx Corp.
$8.79HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
Total return — NERV vs OPRX
growth of $100 · dividends reinvested · last 10yNERV -97.0% (-29.7%/yr)OPRX +169.1% (+10.4%/yr)OPRX compounded faster over this window
Log scale — wide-divergence pair
NERV OPRX
NERV vs OPRX: by the numbers
- •OPRX is the larger company ($165M vs $160M market cap).
- •OPRX is profitable (4.66% net margin) while NERV runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | NERV | OPRX |
|---|---|---|
| P/E ratio | N/A | 37.63 |
| Forward P/E | N/A | 9.80 |
| P/S ratio | N/A | 1.67 |
| P/B ratio | N/A | 1.26 |
| EV / EBITDA | N/A | 10.38 |
| FCF yield | N/A | 11.13% |
Profitability
| Metric | NERV | OPRX |
|---|---|---|
| Gross margin | 0.00% | 63.30% |
| Operating margin | 0.00% | 11.45% |
| Net margin | 0.00% | 4.66% |
| ROE | N/A | 3.51% |
| ROIC | -38.56% | 4.92% |
Growth (annualized)
| Metric | NERV | OPRX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 13.75% |
| Total return CAGR (5Y) | -22.14% | -36.23% |
Frequently asked
- Is NERV or OPRX more profitable?
- OPRX runs the higher net margin — NERV at 0.00% versus OPRX at 4.66%.
- How have NERV and OPRX total returns compared?
- Over the past 10 years, NERV delivered -29.77% and OPRX delivered 10.21% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
OptimizeRx P/E ratioMinerva Neurosciences ROEOptimizeRx ROEMinerva Neurosciences operating marginOptimizeRx operating marginMinerva Neurosciences revenue growthOptimizeRx revenue growthMinerva Neurosciences free cash flowOptimizeRx free cash flow
Minerva Neurosciences & OptimizeRx appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.